Preneoplastic conditions underlying bile duct cancer

Langenbeck's Archives of Surgery

Volumn 397, Issue 6, 2012, Pages 861-867

  Sibulesky, Lena ^a   Nguyen, Justin ^a   Patel, Tushar ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cholangiocarcinoma; Dysplasia; Hepatolithiasis; Liver cancers; Primary sclerosing cholangitis

Indexed keywords

BILE DUCT CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHRONIC BILIARY EPITHELIAL INJURY; CHRONIC INFLAMMATION; COLON CARCINOMA; EPITHELIUM DYSPLASIA; EPITHELIUM HYPERPLASIA; HEPATOBILIARY SYSTEM; HUMAN; MALIGNANT TRANSFORMATION; PANCREAS CANCER; PRECANCER; PRIORITY JOURNAL; REVIEW; STOMACH CARCINOMA;

ANIMALS; BILE DUCT NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; CHOLANGIOCARCINOMA; CHOLANGITIS, SCLEROSING; CHOLELITHIASIS; EARLY DETECTION OF CANCER; FASCIOLA HEPATICA; FEMALE; HUMANS; INCIDENCE; LIVER DISEASES, PARASITIC; LIVER NEOPLASMS; MALE; PRECANCEROUS CONDITIONS; PROGNOSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84865145341     PISSN: 14352443     EISSN: 14352451     Source Type: Journal    
DOI: 10.1007/s00423-012-0943-7     Document Type: Review

References (80)

1. Patel T Cholangiocarcinoma-controversies and challenges. Nat Rev Gastroenterol Hepatol 8 (4):189-200
2. Gatto M, Bragazzi MC, Semeraro R, Napoli C, Gentile R, Torrice A, Gaudio E, Alvaro D Cholangiocarcinoma: update and future perspectives. Dig Liver Dis 42 (4):253-260
3. Alvaro D, Cannizzaro R, Labianca R, Valvo F, Farinati F Cholangiocarcinoma: a position paper by the Italian Society of Gastroenterology (SIGE), the Italian Association of Hospital Gastroenterology (AIGO), the Italian Association of Medical Oncology (AIOM) and the Italian Association of Oncological Radiotherapy (AIRO). Dig Liver Dis 42 (12):831-838
4. B Blechacz GJ Gores 2008 Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment Hepatology 48 1 308 321 18536057 10.1002/hep.22310 1:CAS:528:DC%2BD1cXptFemu70%3D (Pubitemid 351975555)
5. K Okuda Y Nakanuma M Miyazaki 2002 Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology J Gastroenterol Hepatol 17 10 1049 1055 12201863 10.1046/j.1440-1746.2002.02781.x (Pubitemid 35013958)
6. T Ben-Menachem 2007 Risk factors for cholangiocarcinoma Eur J Gastroenterol Hepatol 19 8 615 617 17625428 10.1097/MEG.0b013e328224b935 (Pubitemid 47067057)
7. Alvaro D, Bragazzi MC, Benedetti A, Fabris L, Fava G, Invernizzi P, Marzioni M, Nuzzo G, Strazzabosco M, Stroffolini T Cholangiocarcinoma in Italy: a national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease. Dig Liver Dis 43 (1):60-65
8. U Broome R Olsson L Loof G Bodemar R Hultcrantz A Danielsson H Prytz H Sandberg-Gertzen S Wallerstedt G Lindberg 1996 Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis Gut 38 4 610 615 8707097 10.1136/gut.38.4.610 1:STN:280:DyaK28zjslWltQ%3D%3D (Pubitemid 26111384)
9. Fevery J, Verslype C An update on cholangiocarcinoma associated with primary sclerosing cholangitis. Curr Opin Gastroenterol 26 (3):236-245
10. G Klatskin 1965 Adenocarcinoma of the hepatic duct at tts bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features Am J Med 38 241 256 14256720 10.1016/0002-9343(65)90178-6 1:STN:280:DyaF2M%2FmtFagsA%3D%3D
11. Charbel H, Al-Kawas FH Cholangiocarcinoma: epidemiology, risk factors, pathogenesis, and diagnosis. Curr Gastroenterol Rep 13 (2):182-187
12. SA Khan MB Toledano SD Taylor-Robinson 2008 Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma HPB (Oxford) 10 2 77 82 10.1080/13651820801992641 1:STN:280:DC%2BD1crotl2ktA%3D%3D (Pubitemid 351934989)
13. SA Khan BR Davidson R Goldin SP Pereira WM Rosenberg SD Taylor-Robinson AV Thillainayagam HC Thomas MR Thursz H Wasan 2002 Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document Gut 51 6 VI1 9 12376491 10.1136/gut.51.suppl-6.vi1
14. Tyson GL, El-Serag HB Risk factors for cholangiocarcinoma. Hepatology 54 (1):173-184
15. Yu TH, Yuan RH, Chen YL, Yang WC, Hsu HC, Jeng YM. Viral hepatitis is associated with intrahepatic cholangiocarcinoma with cholangiolar differentiation and N-cadherin expression. Mod Pathol 24 (6):810-819
16. HB El-Serag EA Engels O Landgren E Chiao L Henderson HC Amaratunge TP Giordano 2009 Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans Hepatology 49 1 116 123 19085911 10.1002/hep.22606
17. TY Lee SS Lee SW Jung SH Jeon SC Yun HC Oh S Kwon SK Lee DW Seo MH Kim DJ Suh 2008 Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study Am J Gastroenterol 103 7 1716 1720 18557716 10.1111/j.1572-0241.2008.01796.x
18. TM Welzel BI Graubard HB El-Serag YH Shaib AW Hsing JA Davila KA McGlynn 2007 Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study Clin Gastroenterol Hepatol 5 10 1221 1228 17689296 10.1016/j.cgh.2007.05.020 (Pubitemid 47496233)
19. TM Welzel L Mellemkjaer G Gloria LC Sakoda AW Hsing L El Ghormli JH Olsen KA McGlynn 2007 Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study Int J Cancer 120 3 638 641 17109384 10.1002/ijc.22283 1:CAS:528:DC%2BD28XhtlGqs77M (Pubitemid 46001359)
20. Jing W, Jin G, Zhou X, Zhou Y, Zhang Y, Shao C, Liu R, Hu X Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis. Eur J Cancer Prev 21 (1):24-31
21. Lewis JT, Talwalkar JA, Rosen CB, Smyrk TC, Abraham SC Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma. Am J Surg Pathol 34 (1):27-34
22. Y Zen S Aishima Y Ajioka J Haratake M Kage F Kondo Y Nimura M Sakamoto M Sasaki K Shimamatsu K Wakasa YN Park MF Chen Y Atomi Y Nakanuma 2005 Proposal of histological criteria for intraepithelial atypical/proliferative biliary epithelial lesions of the bile duct in hepatolithiasis with respect to cholangiocarcinoma: preliminary report based on interobserver agreement Pathol Int 55 4 180 188 15826244 10.1111/j.1440-1827.2005.01816.x (Pubitemid 40676927)
23. Y Zen NV Adsay K Bardadin R Colombari L Ferrell H Haga SM Hong P Hytiroglou G Kloppel GY Lauwers DJ van Leeuwen K Notohara K Oshima A Quaglia M Sasaki F Sessa A Suriawinata W Tsui Y Atomi Y Nakanuma 2007 Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria Mod Pathol 20 6 701 709 17431410 10.1038/modpathol.3800788 (Pubitemid 46788877)
24. Rougemont AL, Genevay M, McKee TA, Gremaud M, Mentha G, Rubbia-Brandt L Extensive biliary intraepithelial neoplasia (BilIN) and multifocal early intrahepatic cholangiocarcinoma in non-biliary cirrhosis. Virchows Arch 456 (6):711-717
25. TT Wu M Levy AM Correa CB Rosen SC Abraham 2009 Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases Cancer 115 19 4564 4575 19670455 10.1002/cncr.24471
26. Jain D, Nayak NC Bile duct changes in different etiologic types of end-stage chronic liver disease: a study on native explant livers. J Clin Pathol
27. Y Nakanuma M Sasaki Y Sato X Ren H Ikeda K Harada 2009 Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts World J Hepatol 1 1 35 42 21160963 10.4254/wjh.v1.i1.35
28. Shinozaki A, Shibahara J, Noda N, Tanaka M, Aoki T, Kokudo N, Fukayama M Claudin-18 in biliary neoplasms. Its significance in the classification of intrahepatic cholangiocarcinoma. Virchows Arch 459 (1):73-80
29. Aishima S, Iguchi T, Fujita N, Taketomi A, Maehara Y, Tsuneyoshi M, Oda Y Histological and immunohistological findings in biliary intraepithelial neoplasia arising from a background of chronic biliary disease compared with liver cirrhosis of non-biliary aetiology. Histopathology 59 (5):867-875
30. Nakanuma Y A novel approach to biliary tract pathology based on similarities to pancreatic counterparts: is the biliary tract an incomplete pancreas? Pathol Int 60 (6):419-429
31. K Bickenbach E Galka KK Roggin 2009 Molecular mechanisms of cholangiocarcinogenesis: are biliary intraepithelial neoplasia and intraductal papillary neoplasms of the bile duct precursors to cholangiocarcinoma? Surg Oncol Clin N Am 18 2 215 224 19306808 10.1016/j.soc.2008.12.001 vii
32. K Burak P Angulo TM Pasha K Egan J Petz KD Lindor 2004 Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis Am J Gastroenterol 99 3 523 526 15056096 10.1111/j.1572-0241.2004.04067.x (Pubitemid 38524134)
33. de Valle MB, Bjornsson E, Lindkvist B Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort. Liver Int
34. A Bergquist A Ekbom R Olsson D Kornfeldt L Loof A Danielsson R Hultcrantz S Lindgren H Prytz H Sandberg-Gertzen S Almer F Granath U Broome 2002 Hepatic and extrahepatic malignancies in primary sclerosing cholangitis J Hepatol 36 3 321 327 11867174 10.1016/S0168-8278(01)00288-4 (Pubitemid 34194790)
35. KM Boberg A Bergquist S Mitchell A Pares F Rosina U Broome R Chapman O Fausa T Egeland G Rocca E Schrumpf 2002 Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation Scand J Gastroenterol 37 10 1205 1211 12408527 10.1080/003655202760373434 1:STN:280:DC%2BD38nkvVyltw%3D%3D (Pubitemid 35189610)
36. D Kornfeld A Ekbom T Ihre 1997 Survival and risk of cholangiocarcinoma in patients with primary sclerosing cholangitis. A population-based study Scand J Gastroenterol 32 10 1042 1045 9361178 10.3109/00365529709011222 1:STN:280:DyaK1c%2FislSnsw%3D%3D (Pubitemid 27433668)
37. P Charatcharoenwitthaya FB Enders KC Halling KD Lindor 2008 Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis Hepatology 48 4 1106 1117 18785620 10.1002/hep.22441 1:CAS:528:DC%2BD1cXht1Khu77K
38. TJ Weismuller J Wedemeyer S Kubicka CP Strassburg MP Manns 2008 The challenges in primary sclerosing cholangitis-aetiopathogenesis, autoimmunity, management and malignancy J Hepatol 48 Suppl 1 S38 57 18304683 10.1016/j.jhep.2008.01.020
39. N Chalasani A Baluyut A Ismail A Zaman G Sood R Ghalib TM McCashland KR Reddy X Zervos MA Anbari H Hoen 2000 Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study Hepatology 31 1 7 11 10613720 10.1002/hep.510310103 1:STN:280:DC%2BD3c%2FotVynsQ%3D%3D (Pubitemid 30033681)
40. A Bergquist H Glaumann B Persson U Broome 1998 Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study Hepatology 27 2 311 316 9462625 10.1002/hep.510270201 1:STN:280:DyaK1c7it1CmtQ%3D%3D (Pubitemid 28081041)
41. Razumilava N, Gores GJ, Lindor KD Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology 54 (5):1842-1852
42. E Melum TH Karlsen E Schrumpf A Bergquist E Thorsby KM Boberg BA Lie 2008 Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms Hepatology 47 1 90 96 18023027 10.1002/hep.21964 1:CAS:528:DC%2BD1cXhtlChsr4%3D (Pubitemid 351171045)
43. C de Martel S Franceschi 2009 Infections and cancer: established associations and new hypotheses Crit Rev Oncol Hematol 70 3 183 194 18805702 10.1016/j.critrevonc.2008.07.021
44. B Sripa S Kaewkes P Sithithaworn E Mairiang T Laha M Smout C Pairojkul V Bhudhisawasdi S Tesana B Thinkamrop JM Bethony A Loukas PJ Brindley 2007 Liver fluke induces cholangiocarcinoma PLoS Med 4 7 e201 17622191 10.1371/journal. pmed.0040201 (Pubitemid 47196213)
45. P Watanapa WB Watanapa 2002 Liver fluke-associated cholangiocarcinoma Br J Surg 89 8 962 970 12153620 10.1046/j.1365-2168.2002.02143.x 1:STN:280:DC%2BD38vgsVeitg%3D%3D (Pubitemid 34994687)
46. Tsui WM, Lam PW, Lee WK, Chan YK (2011) Primary hepatolithiasis, recurrent pyogenic cholangitis, and oriental cholangiohepatitis: a tale of 3 countries. Adv Anat Pathol 18(4):318-28
47. Tsui WM, Chan YK, Wong CT, Lo YF, Yeung YW, Lee YW Hepatolithiasis and the syndrome of recurrent pyogenic cholangitis: clinical, radiologic, and pathologic features. Semin Liver Dis 31 (1):33-48
48. T Todani Y Watanabe M Narusue K Tabuchi K Okajima 1977 Congenital bile duct cysts: classification, operative procedures, and review of thirty-seven cases including cancer arising from choledochal cyst Am J Surg 134 2 263 269 889044 10.1016/0002-9610(77)90359-2 1:STN:280:DyaE2s3jvF2gtg%3D%3D (Pubitemid 8160954)
49. J Singham EM Yoshida CH Scudamore 2009 Choledochal cysts: part 1 of 3: classification and pathogenesis Can J Surg 52 5 434 440 19865581
50. M Mesleh DJ Deziel 2008 Bile duct cysts Surg Clin North Am 88 6 1369 1384 18992600 10.1016/j.suc.2008.07.002 x
51. Mabrut JY, Bozio G, Hubert C, Gigot JF Management of congenital bile duct cysts. Dig Surg 27 (1):12-18
52. Lee SE, Jang JY, Lee YJ, Choi DW, Lee WJ, Cho BH, Kim SW Choledochal cyst and associated malignant tumors in adults: a multicenter survey in South Korea. Arch Surg 146 (10):1178-1184
53. AN Ananthakrishnan K Saeian 2007 Caroli's disease: identification and treatment strategy Curr Gastroenterol Rep 9 2 151 155 17418061 10.1007/s11894-007-0010-7 (Pubitemid 46647528)
54. JP Mecklin HJ Jarvinen M Virolainen 1992 The association between cholangiocarcinoma and hereditary nonpolyposis colorectal carcinoma Cancer 69 5 1112 1114 1310886 10.1002/cncr.2820690508 1:STN:280:DyaK387lsVGmsQ%3D%3D
55. JK Kim HK Hwang JS Park SI Cho DS Yoon HS Chi 2008 Left hemihepatectomy and caudate lobectomy and complete extrahepatic bile duct resection using transduodenal approach for hilar cholangiocarcinoma arsing from biliary papillomatosis J Surg Oncol 98 2 139 142 18521837 10.1002/jso.21089
56. M McLoughlin R Enns 2008 Endoscopy in the management of primary sclerosing cholangitis Curr Gastroenterol Rep 10 2 177 185 18462605 10.1007/s11894-008-0040-9
57. YE Chung MJ Kim YN Park JY Choi JY Pyo YC Kim HJ Cho KA Kim SY Choi 2009 Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation Radiographics 29 3 683 700 19448110 10.1148/rg.293085729
58. Morana G, Dorigo A Imaging of cholangiocarcinoma. Cancer Imaging 11:S72-73
59. Gotthardt D, Chahoud F, Sauer P Primary sclerosing cholangitis: diagnostic and therapeutic problems. Dig Dis 29 Suppl 1:41-45
60. Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ Diagnosis and management of primary sclerosing cholangitis. Hepatology 51 (2):660-678
61. E Bjornsson J Lindqvist-Ottosson M Asztely R Olsson 2004 Dominant strictures in patients with primary sclerosing cholangitis Am J Gastroenterol 99 3 502 508 15056092 10.1111/j.1572-0241.2004.04106.x (Pubitemid 38524130)
62. Barr Fritcher EG, Kipp BR, Voss JS, Clayton AC, Lindor KD, Halling KC, Gores GJ Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma. Am J Gastroenterol 106 (11):2023-2028
63. BE Van Beers 2008 Diagnosis of cholangiocarcinoma HPB (Oxford) 10 2 87 93 10.1080/13651820801992716 (Pubitemid 351934991)
64. Riener MO, Vogetseder A, Pestalozzi BC, Clavien PA, Probst-Hensch N, Kristiansen G, Jochum W Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract. Hum Pathol 41 (11):1558-1565
65. Singham J, Yoshida EM, Scudamore CH Choledochal cysts. Part 3 of 3: management. Can J Surg 53 (1):51-56
66. ML Kendrick DM Nagorney 2009 Bile duct cysts: contemporary surgical management Curr Opin Gastroenterol 25 3 240 244 19396963 10.1097/MOG. 0b013e328329887c
67. Cho MJ, Hwang S, Lee YJ, Kim KH, Ahn CS, Moon DB, Lee SK, Kim MH, Lee SS, Park DH, Lee SG Surgical experience of 204 cases of adult choledochal cyst disease over 14 years. World J Surg 35 (5):1094-1102
68. F Ulrich J Pratschke A Pascher UP Neumann E Lopez-Hanninen S Jonas P Neuhaus 2008 Long-term outcome of liver resection and transplantation for Caroli disease and syndrome Ann Surg 247 2 357 364 18216545 10.1097/SLA. 0b013e31815cca88 (Pubitemid 351156782)
69. Wiencke K, Boberg KM Current consensus on the management of primary sclerosing cholangitis. Clin Res Hepatol Gastroenterol 35 (12):786-791
70. IW Graziadei RH Wiesner PJ Marotta MK Porayko JE Hay MR Charlton JJ Poterucha CB Rosen GJ Gores NF LaRusso RA Krom 1999 Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis Hepatology 30 5 1121 1127 10534330 10.1002/hep.510300501 1:STN:280: DC%2BD3c%2FgsVGqug%3D%3D (Pubitemid 29510847)
71. B Brandsaeter H Isoniemi U Broome M Olausson L Backman B Hansen E Schrumpf A Oksanen BG Ericzon K Hockerstedt H Makisalo P Kirkegaard S Friman K Bjoro 2004 Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy J Hepatol 40 5 815 822 15094230 10.1016/j.jhep.2004.01.002 1:STN:280:DC%2BD2c3osl2mug%3D%3D (Pubitemid 38507363)
72. KM Boberg P Jebsen OP Clausen A Foss L Aabakken E Schrumpf 2006 Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis J Hepatol 45 4 568 574 16879890 10.1016/j.jhep.2006.05. 010 (Pubitemid 44307380)
73. A Maheshwari HY Yoo PJ Thuluvath 2004 Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC Am J Gastroenterol 99 3 538 542 15056099 10.1111/j.1572-0241.2004.04050.x (Pubitemid 38524137)
74. JJ Tischendorf A Geier C Trautwein 2008 Current diagnosis and management of primary sclerosing cholangitis Liver Transpl 14 6 735 746 18508363 10.1002/lt.21456 (Pubitemid 351895502)
75. Goldberg D, French B, Thomasson A, Reddy KR, Halpern SD Waitlist survival of patients with primary sclerosing cholangitis in the model for end-stage liver disease era. Liver Transpl 17 (11):1355-1363
76. GJ Gores RG Gish D Sudan CB Rosen 2006 Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia Liver Transpl 12 12 Suppl 3 S95 97 17123289 10.1002/lt.20965 (Pubitemid 44911780)
77. Rosen CB, Heimbach JK, Gores GJ Liver transplantation for cholangiocarcinoma. Transpl Int 23 (7):692-697
78. DJ Rea JK Heimbach CB Rosen MG Haddock SR Alberts WK Kremers GJ Gores DM Nagorney 2005 Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma Ann Surg 242 3 451 458 16135931 discussion 458-461
79. DJ Rea CB Rosen DM Nagorney JK Heimbach GJ Gores 2009 Transplantation for cholangiocarcinoma: when and for whom? Surg Oncol Clin N Am 18 2 325 337 19306815 10.1016/j.soc.2008.12.008 ix
80. Carbone M, Neuberger J Liver transplantation in PBC and PSC: indications and disease recurrence. Clin Res Hepatol Gastroenterol 35 (6-7):446-454